Akebia Therapeutics to Report First Quarter Financial Results and Discuss Recent Business Highlights

Rhea-AI Summary

Akebia Therapeutics, Inc. will release its financial results for Q1 2023 on May 8, 2023, and will host a conference call to discuss the results and recent business highlights.

Positive

• Akebia's financial results for Q1 2023 may positively impact the stock price if they exceed market expectations.

Negative

• No negative takes available.

Akebia to Host Conference Call

CAMBRIDGE, Mass., May 1, 2023 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced plans to release its financial results for the first quarter ended March 31, 2023 on Monday, May 8, 2023, prior to the open of financial markets.

Akebia will host a conference call on Monday, May 8 at 8:30 a.m. ET to discuss its financial results and recent business highlights. To access the call by phone, please click on this Registration Link and you will be provided with dial in details. To avoid delays, we encourage dialing into the conference call fifteen minutes ahead of the scheduled start time.

A live webcast of the conference call will be available via the Investors section of Akebia's website at: https://ir.akebia.com/. An online archive of the webcast can be accessed via the Investors section of Akebia's website at http://ir.akebia.com.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-report-first-quarter-financial-results-and-discuss-recent-business-highlights-301811691.html

SOURCE Akebia Therapeutics

FAQ

When will Akebia Therapeutics release its financial results for Q1 2023?

Akebia Therapeutics will release its financial results for Q1 2023 on May 8, 2023.

What will be discussed in the conference call hosted by Akebia Therapeutics?

The conference call will discuss Akebia's financial results for Q1 2023 and recent business highlights.

Where can I access the webcast of the conference call?

The webcast of the conference call can be accessed via the Investors section of Akebia's website at https://ir.akebia.com/.

How can I access the conference call by phone?

To access the conference call by phone, please click on the Registration Link provided in the PR and you will be provided with dial-in details.

What should I do to avoid delays during the conference call?

To avoid delays, it is encouraged to dial into the conference call fifteen minutes ahead of the scheduled start time.